|

| |
For IMMEDIATE RELEASE
SOPManage™
Product launch by ADS-Limathon Ltd
January 2001
ADS-Limathon Limited have announced the aquisition a new product,
SOPmanage™, from SECHI Ltd of Oxford. The aquisition was initiated in
late 1999, and ADS-Limathon moved quickly to make the product Y2K compliant for
the existing customer base. However the integration into the
ADS-Limathon product range has delayed until now, to ensure that full customer
support is in place for the product.
The
product is used to monitor and control the life-cycle of Quality Documents and
Standard Operating Procedures, ensuring that only the latest version is in
circulation at any given time. The product is an Access runtime database which
works in conjunction with the user’s own copy of MS Word 95 , 97, or 2000, or
Adobe Acrobat, thus allowing the users to create their own template format. Two client versions
are available - an administrator and a read-only viewer. SOPmanage takes care of
the numbering system and the version control enabling administrators to create
new draft procedure documents in MS Word from within the SOPmanage application.
Copies for approval can be easily e-mailed to reviewers and once finally
approved it can be released into the system immediately or in a controlled
manner, sometime in the future. Older versions are automatically lapsed, so the
viewer clients only ever see the current release. SOPmanage also provides
scheduling and reminder facilities to users when document review dates approach
and when drafts are overdue for release. Drafts and copies are printed as
controlled documents with watermarks.
The
product is widely used as part of quality management systems in large
industrial, pharmacuetical, clinical, and health institutions in the UK, US and
Europe, such as Roche Pharmaceuticals, Lagap Pharmaceuticals, Procter &
Gamble Pharmaceuticals , Bayer GmbH, World Health Organisation, and NHS
Hospitals - to name but a few !
For More Information Contact:
ADS-Limathon Limited
3 Ringwood Road, Sheffield, S20 2DG, UK
Tel: +44 (0) 114 251 0820
FAX: +44 (0) 114 247 5771
Internet:
[email protected]
|